APOA5

Apolipoprotein A-V (APOA5) is a protein that in humans is encoded by the APOA5 gene. It is a component of high-density lipoprotein (HDL) and plays a crucial role in lipid metabolism, particularly in the regulation of triglyceride levels.

Function

APOA5 is a member of the apolipoprotein family, proteins that bind lipids to form lipoproteins. It is primarily produced in the liver and secreted into the bloodstream, where it associates with HDL. APOA5 plays a key role in triglyceride metabolism by stimulating the breakdown of triglycerides by lipoprotein lipase (LPL) and inhibiting the synthesis of triglycerides in the liver.

Clinical significance

Variations in the APOA5 gene have been associated with hypertriglyceridemia, a condition characterized by elevated levels of triglycerides in the blood. This can increase the risk of pancreatitis and cardiovascular disease. Studies have also suggested a link between APOA5 gene variations and susceptibility to metabolic syndrome and type 2 diabetes.

Research

Research into the role of APOA5 in lipid metabolism and disease susceptibility is ongoing. Understanding the function of this protein and its associated gene variations could lead to new treatments for conditions related to abnormal lipid metabolism.

See also

• Apolipoprotein
• Hypertriglyceridemia
• Lipoprotein lipase
• Metabolic syndrome
• Type 2 diabetes

APOA5 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia